Hernandez Marlow's Form 4 filing
Cano Health, Inc. (CANO) · filed Sep 8, 2021
- Accession no.
- 0000899243-21-035339
- Filed
- Sep 8, 2021
- Trade date
- Sep 4, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 derivative transactions. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hernandez MarlowCIK 0001865483 | Director, Officer (CEO and President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
These securities were purchased from existing stockholders of the Issuer in private transactions. The combined price per each one share of Class B Common Stock and one PCIH Common Unit was negotiated on an arm's-length basis and determined based on the opening price of Cano's Class A Common Stock on August 16, 2021.
Referenced by the price of 2 transactions in Table II.